For many, EndoTech is a renowned name in the world of artificial intelligence (AI) and financial technology (FinTech).
But for the cofounders, Dr. Anna Becker and Dmitry Gooshchin, it is the culmination of a career focused on Financial AI. A career that is punctuated by significant milestones and transformative contributions, shaping her trajectory in AI and FinTech.
Dr. Becker’s journey was profoundly influenced by her strong academic background, marked by her achievement of a PhD in Artificial Intelligence from Technion Institute. This academic milestone not only honed her technical acumen but also ignited her deep-seated passion for machine learning and its profound implications for the financial sector.
Prior to the meteoric rise of EndoTech, Dr. Becker had already showcased her entrepreneurial acumen, as evidenced by her role as the Founder and President of Strategy Runner from September 2001 to September 2011. Strategy Runner is a pioneering software company that offers an algorithmic trading platform for futures and forex. It revolutionized the field by automating trading signals and establishing strong partnerships with numerous Tier-1 brokers globally.
Her remarkable journey continued at MF Global, where she served as a Senior executive in Product Management. MF Global, a prominent New York-based broker-dealer, had acquired Strategy Runner Trading, a Chicago-based provider of algorithmic trading solutions. Dr. Becker’s contributions played a significant role in advancing the company’s position in the industry.
Dr. Becker’s tenure at MF Global set the stage for her role as the Founder and Chief Data Scientist at Magic Square and her role in Gilboa Fund of Funds where she advised on hundreds of millions of dollars of algorithmic investments
It was there that she began to see the opportunity in institutional algorithmic investments using AI. Through innovative AI approach and algorithms, she has propelled EndoTech to the forefront of the industry. They have also underscored her dedication to creating sustainable and reliable technology.
Dr. Becker’s career has been recognized through numerous awards and accolades. She has firmly established herself as a prominent figure in the realms of AI and FinTech. Her influential work is widely published in leading journals, further amplifying her voice in the AI community. As a sought-after speaker at industry events and academic forums, she generously shares her groundbreaking insights.
Over more than two decades, Dr. Anna Becker’s professional career has shown her indelible impact on the AI-driven financial technology landscape. From her academic journey at Technion to her transformative leadership at EndoTech, her career has been defined by concrete milestones and an unwavering commitment to innovation.
As EndoTech continues to evolve, Dr. Becker remains at the helm, steering the company towards new frontiers in financial technology. The journey is far from over, and with advancements in artificial intelligence and machine learning, EndoTech remains poised to shape the future of algorithmic trading.